Initial results from uterine fibroid embolization for symptomatic leiomyomata

James B. Spies, Anthony R. Scialli, Reena C. Jha, Izumi Imaoka, Susan M. Ascher, Vivian M. Fraga, Klemens H. Barth

Research output: Contribution to journalArticle

Abstract

PURPOSE: To evaluate the safety and short-term efficacy of uterine fibroid embolization (UFE) in patients with symptomatic uterine fibroids. MATERIALS AND METHODS: Bilateral UFE was performed in 61 patients with symptomatic uterine leiomyomata during a 16-month period. Imaging was performed before the procedure and at 3 months and 1 year after the procedure. Questionnaires were obtained at regular intervals after the procedure to assess patient outcome. RESULTS: All procedures but one were technically successful. Mean clinical follow-up was 8.7 months. Minor complications occurred in five patients during the follow-up period. All were treated without permanent sequelae. Menstrual bleeding was improved in 89%, with 81% of patients moderately to markedly improved. Pelvic pain and pressure was improved in 96% of patients, with moderate to marked improvement in 79%. At initial imaging follow-up (mean, 4.4 months postprocedure), median uterine volume decreased 34% (P = .0001) and the median dominant fibroid volume decreased 50% (P = .0001). Imaging at 1 year (mean, 12.3 months) after the procedure showed continued reduction with a median uterine volume reduction of 48% (P = .0002) and median dominant fibroid volume decrease of 78% (P = .0002). CONCLUSION: In the authors' initial clinical experience, UFE appears effective in controlling symptoms and substantially reducing fibroid volume with few complications.

Original languageEnglish (US)
Pages (from-to)1149-1157
Number of pages9
JournalJournal of Vascular and Interventional Radiology
Volume10
Issue number9
StatePublished - Oct 1999
Externally publishedYes

Fingerprint

Leiomyoma
Pelvic Pain
Hemorrhage
Safety
Pressure

Keywords

  • Fibroid
  • Uterine arteries, therapeutic blockade
  • Uterus, neoplasms

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Spies, J. B., Scialli, A. R., Jha, R. C., Imaoka, I., Ascher, S. M., Fraga, V. M., & Barth, K. H. (1999). Initial results from uterine fibroid embolization for symptomatic leiomyomata. Journal of Vascular and Interventional Radiology, 10(9), 1149-1157.

Initial results from uterine fibroid embolization for symptomatic leiomyomata. / Spies, James B.; Scialli, Anthony R.; Jha, Reena C.; Imaoka, Izumi; Ascher, Susan M.; Fraga, Vivian M.; Barth, Klemens H.

In: Journal of Vascular and Interventional Radiology, Vol. 10, No. 9, 10.1999, p. 1149-1157.

Research output: Contribution to journalArticle

Spies, JB, Scialli, AR, Jha, RC, Imaoka, I, Ascher, SM, Fraga, VM & Barth, KH 1999, 'Initial results from uterine fibroid embolization for symptomatic leiomyomata', Journal of Vascular and Interventional Radiology, vol. 10, no. 9, pp. 1149-1157.
Spies JB, Scialli AR, Jha RC, Imaoka I, Ascher SM, Fraga VM et al. Initial results from uterine fibroid embolization for symptomatic leiomyomata. Journal of Vascular and Interventional Radiology. 1999 Oct;10(9):1149-1157.
Spies, James B. ; Scialli, Anthony R. ; Jha, Reena C. ; Imaoka, Izumi ; Ascher, Susan M. ; Fraga, Vivian M. ; Barth, Klemens H. / Initial results from uterine fibroid embolization for symptomatic leiomyomata. In: Journal of Vascular and Interventional Radiology. 1999 ; Vol. 10, No. 9. pp. 1149-1157.
@article{e61bdb63fd9d4e8ea16b3a785d751fba,
title = "Initial results from uterine fibroid embolization for symptomatic leiomyomata",
abstract = "PURPOSE: To evaluate the safety and short-term efficacy of uterine fibroid embolization (UFE) in patients with symptomatic uterine fibroids. MATERIALS AND METHODS: Bilateral UFE was performed in 61 patients with symptomatic uterine leiomyomata during a 16-month period. Imaging was performed before the procedure and at 3 months and 1 year after the procedure. Questionnaires were obtained at regular intervals after the procedure to assess patient outcome. RESULTS: All procedures but one were technically successful. Mean clinical follow-up was 8.7 months. Minor complications occurred in five patients during the follow-up period. All were treated without permanent sequelae. Menstrual bleeding was improved in 89{\%}, with 81{\%} of patients moderately to markedly improved. Pelvic pain and pressure was improved in 96{\%} of patients, with moderate to marked improvement in 79{\%}. At initial imaging follow-up (mean, 4.4 months postprocedure), median uterine volume decreased 34{\%} (P = .0001) and the median dominant fibroid volume decreased 50{\%} (P = .0001). Imaging at 1 year (mean, 12.3 months) after the procedure showed continued reduction with a median uterine volume reduction of 48{\%} (P = .0002) and median dominant fibroid volume decrease of 78{\%} (P = .0002). CONCLUSION: In the authors' initial clinical experience, UFE appears effective in controlling symptoms and substantially reducing fibroid volume with few complications.",
keywords = "Fibroid, Uterine arteries, therapeutic blockade, Uterus, neoplasms",
author = "Spies, {James B.} and Scialli, {Anthony R.} and Jha, {Reena C.} and Izumi Imaoka and Ascher, {Susan M.} and Fraga, {Vivian M.} and Barth, {Klemens H.}",
year = "1999",
month = "10",
language = "English (US)",
volume = "10",
pages = "1149--1157",
journal = "Journal of Vascular and Interventional Radiology",
issn = "1051-0443",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Initial results from uterine fibroid embolization for symptomatic leiomyomata

AU - Spies, James B.

AU - Scialli, Anthony R.

AU - Jha, Reena C.

AU - Imaoka, Izumi

AU - Ascher, Susan M.

AU - Fraga, Vivian M.

AU - Barth, Klemens H.

PY - 1999/10

Y1 - 1999/10

N2 - PURPOSE: To evaluate the safety and short-term efficacy of uterine fibroid embolization (UFE) in patients with symptomatic uterine fibroids. MATERIALS AND METHODS: Bilateral UFE was performed in 61 patients with symptomatic uterine leiomyomata during a 16-month period. Imaging was performed before the procedure and at 3 months and 1 year after the procedure. Questionnaires were obtained at regular intervals after the procedure to assess patient outcome. RESULTS: All procedures but one were technically successful. Mean clinical follow-up was 8.7 months. Minor complications occurred in five patients during the follow-up period. All were treated without permanent sequelae. Menstrual bleeding was improved in 89%, with 81% of patients moderately to markedly improved. Pelvic pain and pressure was improved in 96% of patients, with moderate to marked improvement in 79%. At initial imaging follow-up (mean, 4.4 months postprocedure), median uterine volume decreased 34% (P = .0001) and the median dominant fibroid volume decreased 50% (P = .0001). Imaging at 1 year (mean, 12.3 months) after the procedure showed continued reduction with a median uterine volume reduction of 48% (P = .0002) and median dominant fibroid volume decrease of 78% (P = .0002). CONCLUSION: In the authors' initial clinical experience, UFE appears effective in controlling symptoms and substantially reducing fibroid volume with few complications.

AB - PURPOSE: To evaluate the safety and short-term efficacy of uterine fibroid embolization (UFE) in patients with symptomatic uterine fibroids. MATERIALS AND METHODS: Bilateral UFE was performed in 61 patients with symptomatic uterine leiomyomata during a 16-month period. Imaging was performed before the procedure and at 3 months and 1 year after the procedure. Questionnaires were obtained at regular intervals after the procedure to assess patient outcome. RESULTS: All procedures but one were technically successful. Mean clinical follow-up was 8.7 months. Minor complications occurred in five patients during the follow-up period. All were treated without permanent sequelae. Menstrual bleeding was improved in 89%, with 81% of patients moderately to markedly improved. Pelvic pain and pressure was improved in 96% of patients, with moderate to marked improvement in 79%. At initial imaging follow-up (mean, 4.4 months postprocedure), median uterine volume decreased 34% (P = .0001) and the median dominant fibroid volume decreased 50% (P = .0001). Imaging at 1 year (mean, 12.3 months) after the procedure showed continued reduction with a median uterine volume reduction of 48% (P = .0002) and median dominant fibroid volume decrease of 78% (P = .0002). CONCLUSION: In the authors' initial clinical experience, UFE appears effective in controlling symptoms and substantially reducing fibroid volume with few complications.

KW - Fibroid

KW - Uterine arteries, therapeutic blockade

KW - Uterus, neoplasms

UR - http://www.scopus.com/inward/record.url?scp=0032883358&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032883358&partnerID=8YFLogxK

M3 - Article

C2 - 10527190

AN - SCOPUS:0032883358

VL - 10

SP - 1149

EP - 1157

JO - Journal of Vascular and Interventional Radiology

JF - Journal of Vascular and Interventional Radiology

SN - 1051-0443

IS - 9

ER -